1Antunes G,Neville E,Duffy J,et al.BTS guidelines for the management of malignant pleural effusions.Thorax,2003,58(Suppl 2):29-38.
2Rehse DH,Aye RW,Florence MG.Respiratory failure following talc pleurodesis.Am J Surg,1999,177(5):437-440.
3Campos JR,Werebe EC,Vargas FS,et al.Respiratory failure due to insufflated talc.Lancet,1997,349(9047):251-252.
4Wearherhead M,Antunes G.Chemotherapeutic management of malignant pleural effusion.Expert Opin.Pharmacother,2004,5(6):1233-1242.
5Drynck R,Zhang YE.Smad-dependent and Smad-independent pathways in TGF-beta family signalling.Nature,2003,425(6958):577-584.
6van den Heuvel MM,Smit HJ,Barbierato SB,et al.Talc-induced inflammation in the pleural cavity.Eur Respir J,1998,12(6):1419-1423.
7Marchi E,Vargas FS,Acencio MM,et al.Talc and silver nitrate induce systemic inflammatory effects during the acute phase of experimental pleurodesis in rabbits.Chest,2004,125(6):2268-2277.
8Xie C,Teixeira LR,McGovern JP,et al.Systemic corticosteroids decrease the effectiveness of talc pleurodesis.Am J Respir Crit Care Med,1998,157(5):1441-1444.
